Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Ferraro

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 15, 2017
Diagnostics of anti-MAG antibody polyneuropathyDiego Franciotta, Matteo Gastaldi, Luana Benedetti, et al.
Journal of Neurology|July 6, 2020
Cell-based assays for the detection of MOG antibodies: a comparative studyMatteo Gastaldi, Silvia Scaranzin, Sven Jarius, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Biomolecules|May 28, 2022
Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain MeasurementsPatrizia Natali, Roberta Bedin, Gaetano Bernardi, et al.
Neurology|May 3, 2019
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal studyMassimiliano Calabrese, Claudio Gasperini, Carla Tortorella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2020
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS scoreAmy Kunchok, Jeannette Lechner-Scott, Franco Granella, et al.
Journal of Neurology|August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosisMarta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
Journal of Neuroimmunology|August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumabAlessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 15, 2017
Diagnostics of anti-MAG antibody polyneuropathyDiego Franciotta, Matteo Gastaldi, Luana Benedetti, et al.
Journal of Neurology|July 6, 2020
Cell-based assays for the detection of MOG antibodies: a comparative studyMatteo Gastaldi, Silvia Scaranzin, Sven Jarius, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Biomolecules|May 28, 2022
Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain MeasurementsPatrizia Natali, Roberta Bedin, Gaetano Bernardi, et al.
Neurology|May 3, 2019
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal studyMassimiliano Calabrese, Claudio Gasperini, Carla Tortorella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2020
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS scoreAmy Kunchok, Jeannette Lechner-Scott, Franco Granella, et al.
Journal of Neurology|August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosisMarta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
Journal of Neuroimmunology|August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumabAlessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.
Pageof 13